GLP1R and type 2 diabetes mellitus: For instance, it was shown in patients with type 2 diabetes that Exenatide, another GLP‐1 analogue, increased endothelial function, as assessed in vivo by peripheral arterial tonometry and ex vivo on human subcutaneous adipose tissue arterioles and endothelial cells.31